BRAF and thyroid gland carcinoma: In thyroid cancer, point mutations in Ras and BRAF genes, as well as rearrangements of the RET gene (RET/PTC), lead to the constitutive activation of MAPK pathways that initiate and/or sustain thyroid tumorigenesis19.